Congress Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.15M | Sell |
|
|||||
|
2022
Q2 | $1.64M | Buy |
|
|||||
|
2022
Q1 | $3.6M | Buy |
|
|||||
|
2021
Q4 | $3.18M | Buy |
|
|||||
|
2021
Q3 | $2.83M | Buy |
|
|||||
|
2021
Q2 | $2.44M | Buy |
|
|||||
|
2021
Q1 | $1.05M | Buy |
|
|||||
|
2020
Q4 | $646K | Sell |
|
|||||
|
2020
Q3 | $764K | Hold |
|
|||||
|
2020
Q2 | $646K | Buy |
|
|||||
|
2020
Q1 | $439K | Buy |
|